Growth momentum StudyKIK operates in the clinical trial recruitment and retention space with a revenue range of 25 to 50 million, indicating strong market demand and potential upsell opportunities for expanded programs, especially given its recent acquisition history by Syneos Health and ongoing investments in patient-centric technology.

Client expansion The company provides end-to-end recruitment, retention tech, and telemedicine capabilities for patients, sites, CROs, and sponsors, suggesting opportunities to upsell integrated solutions across sponsor portfolios and broaden site network engagement.

Global leadership Positioned as a global leader in patient recruitment and retention strategy and implementation, StudyKIK offers a compelling value proposition for trials requiring scalable, indication-specific outreach and retention analytics to meet timelines and budgets.

Technology stack Utilizes a broad tech stack including Microsoft Advertising, Adobe Experience Cloud, and analytics tools, enabling data-driven outreach and optimization; potential to propose advanced targeting, measurement, and onboarding enhancements for new studies.

Awards and credibility Recognition such as the Participation Engagement Award for oncology study apps enhances credibility with sponsors seeking innovative engagement approaches, presenting a talking point for differentiating proposals and justifying premium pricing.